Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lynn Dressler"'
Autor:
Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jacob Hagen, Vincent Giamo, Jonathan Andreas, Felicia L. Lenzo, Wang Yirong, Grace K. Dy, Edwin Yau, Amy Early, Hongbin Chen, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Daniele Marin, Jason Zhu, Jeff Clarke, Matthew Labriola, Shannon McCall, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Arun Singavi, Ben George, Andrew Craig MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Lynn Dressler, Mark Steciuk, Oliver Binns, Deepa Kasuganti, Neel Shah, Marc Ernstoff, Kunle Odunsi, Razelle Kurzrock, Mark Gardner, Lorenzo Galluzzi, Carl Morrison
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local immunosuppression independent of major ICI targets (e.g., PD-1). Clinical experience with response prediction based on PD-L1 expression suggests that other
Externí odkaz:
https://doaj.org/article/4f4efc20d258452fa94c335442c051f9
Autor:
Andrew Craig MacKinnon, Kunle Odunsi, Lynn Dressler, Vincent Giamo, Mark Gardner, Matthew Labriola, Mark R Steciuk, Laura J. Tafe, Ben George, Jacob Hagen, Hongbin Chen, Jeffrey M. Conroy, Isabel Araujo-Fernandez, Konstantin H. Dragnev, Oliver A Binns, Wiam Bshara, Jeffrey M. Clarke, Tian Zhang, Edwin Yau, Mary Nesline, Deepa Kasuganti, Felicia L. Lenzo, Neel Shah, Matthew Zibelman, Sean T. Glenn, Blake Burgher, Marc S. Ernstoff, Jonathan Andreas, Rajbir Singh, Katherine G. Madden, Wang Yirong, Grace K. Dy, Pooja Ghatalia, Jonathan Thompson, Robin Jacob, Keisuke Shirai, Arun K Singavi, Daniele Marin, Antonios Papanicolau-Sengos, Sarabjot Pabla, Jason Zhu, Amy P. Early, Razelle Kurzrock, Carl Morrison, Shannon J. McCall, Lorenzo Galluzzi
Publikováno v:
Journal for immunotherapy of cancer, vol 7, iss 1
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Background Resistance to immune checkpoint inhibitors (ICIs) has been linked to local immunosuppression independent of major ICI targets (e.g., PD-1). Clinical experience with response prediction based on PD-L1 expression suggests that other factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b943366b5609140ecd0641fc7b25e61
https://escholarship.org/uc/item/5gr3z6s1
https://escholarship.org/uc/item/5gr3z6s1
Autor:
Ellen Wright, Clayton, Maureen, Smith, Stephanie M, Fullerton, Wylie, Burke, Catherine A, McCarty, Barbara A, Koenig, Amy L, McGuire, Laura M, Beskow, Lynn, Dressler, Amy A, Lemke, Erin M, Ramos, Laura Lyman, Rodriguez, Teri, Manolio
Publikováno v:
Genetics in Medicine. 12:616-620
Increasingly, genomic research is being conducted through large, multi-site consortia. For example, the eMERGE (Electronic Medical Records and Genomics) Consortium was funded by the National Human Genome Research Institute to evaluate the scientific
Autor:
Judy E, Garber, Susan, Halabi, Sara M, Tolaney, Ellen, Kaplan, Laura, Archer, James N, Atkins, Stephen, Edge, Charles L, Shapiro, Lynn, Dressler, Electra D, Paskett, Electra M, Paskett, Gretchen, Kimmick, James, Orcutt, Anthony, Scalzo, Eric, Winer, Ellis, Levine, Nasir, Shahab, Nancy, Berliner
Publikováno v:
JNCI Journal of the National Cancer Institute. 102:942-949
More people receive tamoxifen for cancer than any other drug or therapy (1). Tamoxifen improves disease-free and overall survival as an adjuvant treatment for pre- and postmenopausal patients with hormone receptor–positive breast cancer (2), induce
Autor:
Kathleen, Conway, Sharon N, Edmiston, Lisa, Cui, S Scott, Drouin, Jingzhong, Pang, Mei, He, Chiu-Kit, Tse, Joseph, Geradts, Lynn, Dressler, Edison T, Liu, Robert, Millikan, Beth, Newman
Publikováno v:
Cancer research. 62(7)
To explore the role of smoking in breast cancer, we undertook a population-based study to evaluate the prevalence and spectrum of p53 mutations in the breast tumors of smokers and nonsmokers. We evaluated 456 archival invasive breast tumors for mutat
Autor:
Beth Newman, Chiu-Kit Tse, Patricia Moorman, Lynn Dressler, Miriam Labbok, Joseph Geradts, Sarah Nyante, Chad Livasy, Lisa Carey, H. Earp
Publikováno v:
Breast Cancer Research & Treatment; May2008, Vol. 109 Issue 1, p141-141, 1p